Covaxin booster dose trial shows 'long-term safety': Bharat Biotech
Based on emerging data, Bharat Biotech believes that a third dose may be beneficial to maintain the highest levels of protection.
Jan 08, 2022, 21:45 PM IST
Bharat Biotech gets DCGI nod to test nasal COVID-19 vaccine as booster shot
India's drug regulator DCGI on Wednesday granted approval to Bharat Biotech for conducting late-stage trials of its nasal COVID-19 vaccine to be used as a booster shot, according to news agency ANI.
Jan 05, 2022, 11:44 AM IST
'Proven record for safety': Bharat Biotech after Covaxin gets emergency usage nod for kids above 12 years
"Covaxin has established a proven record for safety and efficacy in adults for the original variant and subsequent variants. We have documented excellent safety and immunogenicity data readouts in Children," Bharat Biotech said.
Dec 26, 2021, 06:16 AM IST
Bharat Biotech seeks DCGI nod for India's 1st intranasal COVID vaccine
Bharat Biotech submitted a phase 3 clinical trial application to the Drugs Controller General of India.
Dec 20, 2021, 20:03 PM IST
Omicron threat: People with health issues or inactivated vaccine should get booster dose, says WHO
Many countries have been rolling out booster shots, targeting the elderly and people with underlying health issues.
Dec 09, 2021, 16:43 PM IST
Covaxin for kids aged 2-18, Centre examining Expert Committee recommendations
The Central government is examining the recommendation to grant market authorization to Covaxin for the age group of 2 to 18 years.
Nov 30, 2021, 23:55 PM IST
Covaxin 50% effective against symptomatic Covid cases: Lancet study
The Delta variant was the dominant strain in India during the study period, accounting for approximately 80 per cent of all confirmed Covid-19 cases.
Nov 25, 2021, 10:53 AM IST
Good news! UK adds India-made Covaxin to its list of approved COVID-19 vaccines
It will benefit more fully vaccinated Indians planning travel to the UK without the need for a pre-departure PCR test or self-isolation at the address declared on their compulsory Passenger Locator Forms.
Nov 23, 2021, 08:11 AM IST
Developing Covaxin in ‘just 10 months’ was an enormous challenge: Bharat Biotech
Addressing a session on Thursday at the Bengaluru Tech Summit-2021, Bharat Biotech Director, V Krishna Mohan said there were no vaccines when the Covid-19 hit India, and the world.
Nov 19, 2021, 06:22 AM IST
Covaxin found to have 77.8 per cent efficacy rate against COVID-19: Lancet
Covaxin, the coronavirus vaccine developed by the government's medical research agency and Bharat Biotech, was found to have a 77.8 per cent efficacy rate against COVID-19. This report was published in a long-awaited analysis published in The Lancet.
Nov 12, 2021, 14:44 PM IST
Bharat Biotech's Covaxin shows 77.8 % efficacy against COVID: Lancet study
"COVAXIN is the only COVID-19 vaccine to have demonstrated efficacy data from phase III clinical trials against the delta variant at 65.2 per cent," the official statement issued by Bharat Biotech said citing the study by the Lancet.
Nov 12, 2021, 10:21 AM IST
From court's relief for Rhea Chakraborty to Chhath Puja celebrations, here are top news headlines
Here's what making a buzz!
Nov 11, 2021, 08:26 AM IST
Six months after second COVID jab ideal time for booster dose: Bharat Biotech CMD
About the nasal vaccine being developed by Bharat Biotech after its Coavaxin, Dr Krishna Ella said that the Phase 2 trials are done and data was being analysed. "We should expect it in 3-4 months," he said, adding that Bharat Biotech was also talking to the government about using the Cowin platform for doing clinical trials.
Nov 11, 2021, 06:48 AM IST
After COVID-19 vaccines, Bharat Biotech ventures into processed organic food business
Presently available only on online platforms, the products are pickles in low sodium, cryogenic and sugar-free beverages, microbial-free rice, seasonings, spices, and probiotic instant foods.
Nov 09, 2021, 20:50 PM IST
Good news for Indian travellers! UK to add Covaxin to approved list from November 22
The move follows the World Health Organisation's (WHO) Emergency Use Listing for Covaxin, which is the second most used formulation in India. Covishield, the India-manufactured Oxford-AstraZeneca COVID-19 vaccine, was added to the UK's approved list last month.
Nov 09, 2021, 06:18 AM IST
Covaxin for kids: Bharat Biotech's partner requests approval for ages 2-18 in US
Bharat Biotech's US partner Ocugen has approached US Food and Drug Administration (FDA) for Emergency Use Authorisation (EUA) of Covaxin for children below 18
Nov 06, 2021, 11:23 AM IST
WHO's approval to Covaxin will facilitate foreign travel for Indians: EAM S Jaishankar
The World Health Organisation (WHO) had on Wednesday granted emergency use approval for Bharat Biotech's COVID-19 vaccine Covaxin, in a move that the pharma major said is a "significant" step towards ensuring wider global access to the indigenously developed jab.
Nov 04, 2021, 07:51 AM IST
A shot in the arm for India! Bharat Biotech's Covaxin gets WHO approval for emergency use
The Technical Advisory Group (TAG)-Emergency use listing (EUL) is an independent advisory group that provides recommendations to WHO on whether a COVID-19 vaccine can be listed for emergency use under the EUL procedure.
Nov 03, 2021, 17:26 PM IST
DNA Exclusive: Is WHO biased against India's Covaxin? Read here
Zee News Editor-in-Chief Sudhir Chaudhary on Friday analysed if the World Health Organisation is biased towards Covaxin even as Bharat Biotech awaits its approval for emergency use lisitng.
Oct 29, 2021, 23:12 PM IST
‘Bharat Biotech submitting data regularly, very quickly': WHO official on Covaxin approval
"Let me say that Bharat has been submitting data regularly and very quickly, but they submitted the last batch of data on the 18th of October," Dr Mariangela Simao, Assistant Director-General said.
Oct 29, 2021, 07:26 AM IST
